Grade 3 Meningioma — Trials

Grade 3 Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

41 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 7
Ph III recruiting: 0
Growth YoY: —
Industry share: 10%
Top sponsor: Emory University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02973256	Oncological Care for Patients With Meningioma(ATYPICMENING)	unknown	—	1,204	University Hospital, MontpellierOTHER	1	Apr 14, 2022	clinicaltrials
NCT04728568	Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma	unknown	N/A	15	Beijing Tiantan HospitalOTHER	1	Aug 10, 2021	clinicaltrials